Advisory Research Inc Ligand Pharmaceuticals Inc Transaction History

Advisory Research Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$105.93 - $142.47 $391,623 - $526,711	-3,697 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$128.36 - $272.13 $200,113 - $424,250	-1,559 Reduced 29.66%	3,697 $502,000
Q3 2018 Nov 13, 2018	SELL	$211.18 - $274.49 $829,303 - $1.08 Million	-3,927 Reduced 42.76%	5,256 $1.44 Million
Q2 2018 Aug 14, 2018	SELL	$150.77 - $207.98 $3,920 - $5,407	-26 Reduced 0.28%	9,183 $1.9 Million
Q1 2018 May 15, 2018	BUY	$138.63 - $182.62 $1.28 Million - $1.68 Million	9,209 New	9,209 $1.52 Million

277

18.5M

30.8K

5.2K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.83B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

Stay updated on Advisory Research Inc with notifications on news.